Summary
RMC No. 27-2026 publishes the full text of the February 6, 2026 letter from the Food and Drug Administration (FDA) endorsing the updated full list of VAT-exempt drugs under RA No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act).
CollapseExpand
Key points
- Exempt drugs by illness. The list covers Cancer (702), Diabetes (327), High Cholesterol (171), Hypertension (535), Kidney Disease (152), Mental Illness (300), and Tuberculosis (76).
- Earlier circulars superseded. Previously issued Revenue Memorandum Circulars on this list are superseded until the FDA endorses new updates.
Deadlines and effectivity
- FDA letter dated: February 6, 2026
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.
